中證(zheng)網訊(實習(xi)記(ji)者 宋維東)2月26日晚,哈藥股份(fen)(600664)發布公告,鑒于重(zhong)大資產重(zhong)組事項已終止,公司股票將(jiang)于2月27日開(kai)市起復牌。
據(ju)悉,哈藥(yao)(yao)股(gu)(gu)份(fen)(fen)因實際控(kong)制人哈爾濱(bin)市國資委籌劃(hua)與(yu)(yu)哈藥(yao)(yao)集團(tuan)(tuan)相關的(de)(de)重(zhong)(zhong)大(da)事項,于2017年9月(yue)(yue)28日(ri)起停(ting)牌。2017年10月(yue)(yue)19日(ri),因控(kong)股(gu)(gu)子公(gong)司人民同泰籌劃(hua)資產(chan)(chan)購買的(de)(de)重(zhong)(zhong)大(da)事項,對(dui)哈藥(yao)(yao)股(gu)(gu)份(fen)(fen)也構(gou)(gou)成重(zhong)(zhong)大(da)資產(chan)(chan)重(zhong)(zhong)組(zu),股(gu)(gu)票自2017年10月(yue)(yue)19日(ri)起繼續停(ting)牌,進入重(zhong)(zhong)大(da)資產(chan)(chan)重(zhong)(zhong)組(zu)程序。2018年2月(yue)(yue)13日(ri),哈藥(yao)(yao)集團(tuan)(tuan)已與(yu)(yu)GNC簽(qian)署(shu)購買協(xie)(xie)議(yi),同日(ri),哈藥(yao)(yao)股(gu)(gu)份(fen)(fen)與(yu)(yu)哈藥(yao)(yao)集團(tuan)(tuan)簽(qian)署(shu)了(le)附生效條件(jian)的(de)(de)《安排協(xie)(xie)議(yi)》,協(xie)(xie)議(yi)規定哈藥(yao)(yao)集團(tuan)(tuan)安排哈藥(yao)(yao)股(gu)(gu)份(fen)(fen)作(zuo)為(wei)履約(yue)主體,交(jiao)(jiao)易(yi)方案(an)為(wei)認購GNC優先(xian)股(gu)(gu),交(jiao)(jiao)易(yi)金(jin)額(e)為(wei)299950000美元, 交(jiao)(jiao)易(yi)方案(an)不構(gou)(gou)成重(zhong)(zhong)大(da)資產(chan)(chan)重(zhong)(zhong)組(zu),屬對(dui)外(wai)投資行為(wei)。根據(ju)相關規定和要求,哈藥(yao)(yao)股(gu)(gu)份(fen)(fen)決定終(zhong)(zhong)止本(ben)次重(zhong)(zhong)大(da)資產(chan)(chan)重(zhong)(zhong)組(zu)事項,并于2月(yue)(yue)26日(ri)召開了(le)終(zhong)(zhong)止重(zhong)(zhong)大(da)資產(chan)(chan)重(zhong)(zhong)組(zu)事項投資者說明(ming)會。